| Total | UPL | MPL |  | Crude β (95% CI) | p-value | Adjusted β (95% CI) | p-value |
---|---|---|---|---|---|---|---|---|
Sample size (n) and weighted prevalence (%) | n = 1035 (100%) | n = 765 (68.4%) | n = 270 (31.6%) |  |  |  |  |  |
HOOS/KOOS | 66.00 | 58.36 | 83.06 | UPL | −24.70 | < 0.001 | −21.28 | < 0.001 |
ADL, mean ± SD | ±23.08 | ±21.31 | ±16.96 |  | (−28.60, −20.80) |  | (−24.81, −17.76) |  |
HOOS/KOOS | 50.55 | 43.09 | 67.00 | UPL | −23.91 | < 0.001 | −21.19 | < 0.001 |
QoL, mean ± SD | ±22.45 | ±19.37 | ±19.88 |  | (−28.31, −19.51) |  | (−25.22, −17.16) |  |
 |  |  |  |  | Crude OR (95% CI) | p-value | Adjusted OR (95% CI) | p-value |
Anxiety | 198 | 161 | 37 (12.8) | UPL | 1.76 | 0.020 | 1.23 | 0.395 |
symptoms, n (%) | (18.1) | (20.6) | Â | Â | (1.09, 2.83) | Â | (0.77, 1.97) | Â |
Depression | 162 | 130 | 32 (12.9) | UPL | 1.49 | 0.235 | 1.11 | 0.744 |
symptoms, n (%) | (16.5) | (18.1) | Â | Â | (0.77, 2.86) | Â | (0.59, 2.12) | Â |